Phumipamorn 2008.

Study characteristics
Methods	Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes Patient RCT, conducted in a community hospital in Krabi Province, mid‐south Thailand Two arms: 1. Control (control arm) and 2. Study (intervention arm)
Participants	Control arm N: 68 Intervention arm N: 67 Diabetes type: type 1 and type 2 Mean age: 54.1 ± 12.4 % Male: 15.9 Longest follow‐up: 8 months
Interventions	Control arm: None Intervention arm: 1) Team changes 2) Patient education 3) Patient reminders
Outcomes	1) HbA1c, mean % (SD) Control arm: pre 8.7 (1.6), post 8.1 (1.9) Intervention arm: pre 8.7 (1.5), post 7.9 (1.4) 2) LDL, mean mg/dL (SD) Control arm: pre 156.6 (32.3), post 165.7 (42.4) Intervention arm: pre 174.4 (48.1), post 159.1 (37.3)
Funding source	This study was supported by research grants from the Graduate School, Prince of Songkla University, and the Provincial Public Health Department of Krabi Province, Thailand
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Information not available.
Allocation concealment (selection bias)	Unclear risk	Information not available.
Patient's baseline characteristics (selection bias)	High risk	Information not available.
Patient's baseline outcomes (selection bias)	High risk	Information not available.
Incomplete outcome data (attrition bias)	Low risk	Information not available.
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias)	Low risk	Information not available.
Selective reporting (reporting bias)	Low risk	Information not available.
Risk of contamination (other bias)	Unclear risk	Information not available.
Other bias	Low risk	Information not available.